Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease - Hebei Province, China, November 2018 to November 2020.

China CDC weekly(2023)

引用 0|浏览14
暂无评分
摘要
Our study supports evidence on recommendations that COPD patients in China are offered both influenza vaccine and PPSV23.
更多
查看译文
关键词
pneumococcal polysaccharide vaccination,influenza,chronic obstructive pulmonary disease,economic burden
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要